retatrutide/cagrilintide Cagrilintide vs Retatrutide for Weight Loss and Metabolic Health RetaCagri Side Effects: Combined GI
Description
Nothing is unusual compared to similar therapies, but stilllong-term safety is part of what ongoing trials are trying to confirm
For one thing, theyve actually been around for two decades
One excellent candidate to do so is DexCom (DXCM 1.71%)
So, its a very bad outcome when it happens," Eimer continued
Bottom line: Grey market peptides cost 30-60% less than domestic research vendors, but you're trading money for risk
